{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T22:34:29Z","timestamp":1791412469363,"version":"4.3.3"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000890","name":"National Multiple Sclerosis Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000890","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.msard.2023.105387","type":"journal-article","created":{"date-parts":[[2023,12,16]],"date-time":"2023-12-16T11:23:27Z","timestamp":1702725807000},"page":"105387","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Inflammatory vaginitis in four B-cell suppressed women with Multiple Sclerosis"],"prefix":"10.1016","volume":"82","author":[{"given":"Libby","family":"Levine","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiyeon","family":"Son","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Wesley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip L.","family":"De Jager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"Moynihan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca Straus","family":"Farber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Rosser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoosna","family":"Haque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2133-9607","authenticated-orcid":false,"given":"Claire S.","family":"Riley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.msard.2023.105387_bib0001","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa1601277","article-title":"Ocrelizumab versus interferon beta-1a in relapsing multiple sclerosis","volume":"376","author":"Hauser","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.msard.2023.105387_bib0002","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2022-250425","article-title":"Inflammatory vaginitis associated with long-term rituximab treatment in a patient with multiple sclerosis","volume":"15","author":"Filikci","year":"2022","journal-title":"BMJ Case Rep."},{"issue":"1","key":"10.1016\/j.msard.2023.105387_bib0003","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1186\/s12905-021-01423-0","article-title":"Inflammatory vaginitis in women on long-term rituximab treatment for autoimmune disorders","volume":"21","author":"Yockey","year":"2021","journal-title":"BMC Womens Health"},{"issue":"2","key":"10.1016\/j.msard.2023.105387_bib0004","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/LGT.0000000000000661","article-title":"Vulvovaginal pyoderma gangrenosum in a patient treated with ocrelizumab for multiple sclerosis","volume":"26","author":"Breneman","year":"2022","journal-title":"J. Low Genit. Tract Dis."},{"key":"10.1016\/j.msard.2023.105387_bib0005","article-title":"It's not always an infection: pyoderma gangrenosum of the urogenital tract in two patients with multiple sclerosis treated with rituximab","volume":"70","author":"Parrotta","year":"2022","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2023.105387_bib0006","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jdcr.2022.08.005","article-title":"Ocrelizumab-induced vulvovaginal pyoderma gangrenosum in a patient with relapsing-remitting multiple sclerosis","volume":"28","author":"Klumpp","year":"2022","journal-title":"JAAD Case Rep."},{"key":"10.1016\/j.msard.2023.105387_bib0007","article-title":"International society for the study of vulvovaginal disease recommendations for the diagnosis and treatment of vaginitis","author":"Vieira-Baptista","year":"2023","journal-title":"Admedic"},{"issue":"4","key":"10.1016\/j.msard.2023.105387_bib0008","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1097\/AOG.0b013e3182117c9e","article-title":"Prognosis and treatment of desquamative inflammatory vaginitis","volume":"117","author":"Sobel","year":"2011","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.msard.2023.105387_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2023.104763","article-title":"Anti-CD20 monoclonal antibody (mAb) therapy and colitis: a case series and review","volume":"75","author":"Tolaymat","year":"2023","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2023.105387_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.103832","article-title":"Disproportional increase in psoriasis reports in association with B cell depleting therapies in patients with multiple sclerosis","volume":"63","author":"Porwal","year":"2022","journal-title":"Mult. Scler. Relat. Disord."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034823008866?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034823008866?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T09:11:24Z","timestamp":1761901884000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034823008866"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":10,"alternative-id":["S2211034823008866"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2023.105387","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inflammatory vaginitis in four B-cell suppressed women with Multiple Sclerosis","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2023.105387","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105387"}}